Cardio Diagnostics Holdings Inc. Warrant financials
$0.01000.00%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 |
|---|---|---|---|---|
| Revenue | $14.8K | $34.9K | $17.1K | $950.00 |
| Gross profit | $14.8K | $34.9K | $17.1K | $950.00 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | -$6.5M | -$8.4M | -$7.2M | -$4.5M |
| Net income | -$6.5M | -$8.4M | -$8.4M | -$4.7M |
| Net margin | −43832.5% | −24028.2% | −49087.8% | −490630.0% |
| Diluted EPS | $-3.71 | $-9.35 | $-19.80 | $-45.30 |
| EBITDA | -$6.1M | -$8.1M | -$7.1M | -$4.5M |
| Operating cash flow | -$5.7M | -$5.0M | -$5.7M | -$5.1M |
| Free cash flow | -$5.9M | -$5.2M | -$6.2M | -$5.1M |
| Diluted shares | 1.8M | 0.9M | 0.4M | 0.1M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & equivalents | $5.1M | $7.8M | $1.3M | $4.1M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $849.0K |
| Total assets | $7.8M | $10.6M | $4.5M | $6.2M |
| Total liabilities | $793.1K | $1.1M | $1.5M | $1.9M |
| Shareholders' equity | $7.0M | $9.6M | $3.0M | $4.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology